QuiVad

Home / Netherlands / Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 3.89% on March 1, 2024. The shaded band matches the twelve months of the first chart.

June 22, 2023 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Vivoryon Therapeutics N.V. by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

92 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 24, 2024GSA Capital Partners LLP0.33%
April 17, 2024Millennium International Management LP1.47%
April 16, 2024Millennium International Management LP1.35%
April 15, 2024Millennium International Management LP1.23%
April 12, 2024Millennium International Management LP1.12%
April 11, 2024Millennium International Management LP0.99%
April 11, 2024GSA Capital Partners LLP0.71%
April 10, 2024Millennium International Management LP0.86%
April 9, 2024Millennium International Management LP0.74%
April 8, 2024Millennium International Management LP0.61%
March 21, 2024GSA Capital Partners LLP0.62%
March 14, 2024GSA Capital Partners LLP0.53%
March 5, 2024Janus Henderson Investors UK Limited0.00%
March 4, 2024Janus Henderson Investors UK Limited1.24%
March 4, 2024Adage Capital Management L.P.0.00%
March 1, 2024Adage Capital Management L.P.0.92%
February 29, 2024Adage Capital Management L.P.0.87%
February 27, 2024Janus Henderson Investors UK Limited2.97%
February 26, 2024Janus Henderson Investors UK Limited2.80%
February 26, 2024Adage Capital Management L.P.0.74%
February 22, 2024Janus Henderson Investors UK Limited2.72%
February 21, 2024Janus Henderson Investors UK Limited2.61%
February 13, 2024Janus Henderson Investors UK Limited2.51%
February 7, 2024Janus Henderson Investors UK Limited2.39%
January 22, 2024Janus Henderson Investors UK Limited2.23%
January 18, 2024Janus Henderson Investors UK Limited2.10%
January 17, 2024Janus Henderson Investors UK Limited2.02%
January 16, 2024Adage Capital Management L.P.0.61%
January 9, 2024Janus Henderson Investors UK Limited1.90%
January 9, 2024Adage Capital Management L.P.0.54%
December 27, 2023Janus Henderson Investors UK Limited1.80%
November 14, 2023Janus Henderson Investors UK Limited1.61%
November 10, 2023Janus Henderson Investors UK Limited1.52%
November 7, 2023Janus Henderson Investors UK Limited1.42%
November 2, 2023Janus Henderson Investors UK Limited1.36%
October 31, 2023Janus Henderson Investors UK Limited1.20%
August 25, 2023Janus Henderson Investors UK Limited1.12%
August 22, 2023Janus Henderson Investors UK Limited1.03%
August 8, 2023Janus Henderson Investors UK Limited0.94%
June 28, 2023Janus Henderson Investors UK Limited0.81%
June 26, 2023Janus Henderson Investors UK Limited0.70%
June 22, 2023Janus Henderson Investors UK Limited0.59%

Download 92 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Vivoryon Therapeutics N.V., source AFM, data as at February 14, 2025, https://www.quivad.com/action/vivoryon-therapeutics-n-v?page=2